This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Company Filing History:
1 out of 834,411 Years Active: 2002
Title: Innovations in Viral Pseudo-Particles: The Work of Javier Sarraseca
Introduction
Javier Sarraseca is an innovative inventor based in Madrid, Spain. He has made significant contributions to the field of virology, particularly in the development of recombinant viral pseudo-particles. His work aims to enhance the immune response against viral infections.
Latest Patents
Javier Sarraseca holds a patent for "Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes." This invention addresses the challenges faced in generating modified viral pseudo-particles that can stably incorporate heterologous antigenic determinants. The patent describes hybrid virus-like particles (VLP) created by self-assembly of a modified porcine parvovirus (PPV) VP2 capsid protein. These particles have shown promise in inducing strong cytotoxic T lymphocyte (CTL) responses and T helper lymphocyte responses in immunized mice.
Career Highlights
Throughout his career, Sarraseca has focused on developing safe and effective strategies for inducing immune responses against virus-infected cells. His innovative approach using baculovirus expression systems for producing recombinant viral pseudo-particles has the potential to advance therapeutic options in virology.
Collaborations
Javier has collaborated with notable colleagues, including Ignacio Casal and Christine Sedlik. Their combined expertise has contributed to the success of his research and the advancement of their shared goals in the field of immunology.
Conclusion
Javier Sarraseca's work in the development of recombinant viral pseudo-particles represents a significant advancement in virology. His innovative approaches have the potential to improve immune responses against viral infections, paving the way for future research and therapeutic applications.